Effects of blood-activating and stasis-resolving drugs on tumor formation and metastasis

Journal of Traditional Chinese Medicine

Volumn 29, Issue 4, 2009, Pages 301-310

  Qian, Yan Fang ^a   Wang, Xiao Jing ^a  

^a General Hospital of Navy of Chinese People's Liberation Army   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING DISORDER; CARCINOGENESIS; CELL ADHESION; CELL INFILTRATION; HEMOSTASIS; HUMAN; MALIGNANT NEOPLASTIC DISEASE; METASTASIS; MICROCIRCULATION; MICROTHROMBUS; REVIEW; TUMOR CELL;

EID: 76549099344     PISSN: 02552922     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0254-6272(09)60089-3     Document Type: Review

References (26)

1. Yang Y, Wang WL, Li QD, et al. ModeRN internal medicine. Beijing: China Press of Traditional Chinese Medicine 2000; 369-379.
2. Li PW, Zou LG, Cheng JH, et al. Clinical oncology in Chinese and Western medicine. Beijing, China Press of Traditional Chinese Medicine 1996; 54.
3. Gao J. Application of examination of nail fold microcirculation in treating tumor. Journal of Sino-Japanese Friendship Hospital 1996; 11: 319-322.
4. Liu CH, Yao YQ. Manifestation of nail fold microcirculation in patients with malignant tumor in the chest. Chinese Journal of Oncology 1984; 8: 250.
5. Zhou AG, Ding YX, Huang DW, et al. Research into the relationship between hyper-coagulative state of patients with gastric malignant tumor on one hand and their ages and clinically pathological stages on the other hand. Tumor 1998; 18: 34-36.
6. Chen JM. Hyper-coagulative state of blood in cancer patients and treatment with blood-activating and stasis-resolving drugs. Journal of Integrated Traditional and Western Medicine 1985; 5: 89-91.
7. Wang YT. Exploration of relationship between advanced lung cancer and thrombocytosis. Journal of Integrated Traditional and Western Medicine 1988; 8: 276.
8. Li GX, Wu HY, Li BF, et al. To probe blood stasis and cancer from platelet adherence of in vitro thrombus. Journal of Integrated Traditional and Western Medicine 1987; 7: 726.
9. Liu YH, Zhang YW, Liang GG, et al. Clinical and experimental research into tumor metastasis and microcosmic blood stasis syndrome. Modern Traditional Chinese Medicine 1996; 9: 224-228.
10. Ma WJ, Cheng GZ. The relationship between hematogenous metastasis and blood viscosity. Intermediate Medical Journal 1992; 27: 7-9.
11. Hou W, Li J. Research into anti-metastasis with strengthening body resistance, removing toxin and promoting blood circulation. Bulletin of Chinese Cancer 1999; 8 : 450-499.
12. Wu JP, Li SH. 39 Cases of tumor in digestive tract treated with blood-activating and stasis-resolving method and chemotherapy. Shaanxi Journal of Traditional Chinese Medicine 1999; 20: 52.
13. Cai WM. Blood-activating and stasis-resolving drugs combined with radiotherapy to treat nasopharyngeal carcinoma. China Radiotherapy Journal 1992; 1: 4.
14. Gao SM. 20 cases of liver cancer treated with Chinese drugs. Shaanxi Journal of Traditional Chinese Medicine 2000; 21: 104.
15. Zhang XW. Using TCM to treat 22 cases of primary liver cancer. Shaanxi Journal of Traditional Chinese Medicine 1999; 20: 393.
16. Yang JQ, Zhang BB. Analysis of clinically therapeutic effect of TCM on 102 cases of gastric cancer at intermediate or late stage. Journal of Traditional Chinese Medicine 2000; 41: 483-484.
17. Xie YM, Zhang CF. Modified Yiguan Jian (An ever effective decoction for nourishing the liver and kidney) used to treat 106 cases of lung cancer. Shaanxi Journal of Traditional Chinese Medicine 2002; 23: 302-303.
18. Zhang YM, Wang XS, Gao YM. Qingyu Fuzheng Tang (Decoction for removing blood stasis and strengthening the body resistance) used to treat 30 cases of gastric cancer at intermediate or late stage. Shaanxi Journal of Traditional Chinese Medicine 2005; 26: 889.
19. Peng YX. TCM method for strengthening the spleen and removing blood stasis used to treat 40 cases of gastric cancer. Shaanxi Journal of Traditional Chinese Medicine 2006; 27: 1037-1038.
20. Xu MS, Li ZB. Yiqi Sanjie Tang (Decoction for reinforcing qi and resolving mass) and Xiao Jie San (Powder for resolving mass) used to treat pain in 80 patients with carcinoma of esophagus at late stage. Shaanxi Journal of Traditional Chinese Medicine 2003; 24: 612.
21. Wei L, Yang CG. 52 Cases of primary liver cancer at late stage treated with combined differentiation of TCM syndrome and disease. Shaanxi Journal of Traditional Chinese Medicine 2002; 23: 585.
22. Pu P, Zhou RQ, Chen QM. Effect of recipe for strengthening the body resistance and removing blood stasis on inhibiting metastasis of gastric cancer after operation and on sub-group of T cells. Journal of Traditional Chinese Medicine 2001; 42: 226-227.
23. Zhang PT, Pei YX, Qi X, et al. Influence of drugs for promoting blood circulation on adherence and invasion by human lung cancer cells. Chinese Journal of Integrative Medicine 1999; 19: 103-105.
24. Xu DC, Zhang PY. Probe into mechanism of relationship between strength of blood-activating and stasis-resolving drugs and metastatic rate of gastric cancer in patients belonging to deficiency of both qi and blood. Journal of Traditional Chinese Medicine 1998; 39: 156-157.
25. Zhong X. Analysis of TCM therapeutic effect on precancerosis of atrophic gastritis. Journal of Gansu TCM College 1998; 15: 14-15.
26. Wang BS, Liu XF, Fu XC, et al. Non-small cell lung cancer at late stage treated with chemotherapy and drugs for reinforcing qi, promoting blood circulation and resolving Mass. Chinese Journal of Surgery of Integrated Traditional and Western Medicine 1999; 5: 203-206.